title: Helminth infection during pregnancy and development of infantile eczema.
authors.forename: Alison M
authors.initials: AM
authors.lastname: Elliott
authors.forename: Harriet
authors.initials: H
authors.lastname: Mpairwe
authors.forename: Maria A
authors.initials: MA
authors.lastname: Quigley
authors.forename: Margaret
authors.initials: M
authors.lastname: Nampijja
authors.forename: Lawrence
authors.initials: L
authors.lastname: Muhangi
authors.forename: James
authors.initials: J
authors.lastname: Oweka-Onyee
authors.forename: Moses
authors.initials: M
authors.lastname: Muwanga
authors.forename: Juliet
authors.initials: J
authors.lastname: Ndibazza
authors.forename: James A G
authors.initials: JA
authors.lastname: Whitworth
mesh_terms: D015766:Albendazole / Q000627:therapeutic use*; D000871:Anthelmintics / Q000627:therapeutic use*; D004485:Eczema / Q000453:epidemiology* / Q000276:immunology; D005260:Female; D006373:Helminthiasis / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D016012:Poisson Distribution; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy* / Q000276:immunology*; D016032:Randomized Controlled Trials as Topic; D012306:Risk
chemical_list: D000871:Anthelmintics; D015766:Albendazole